iLabService
-58%
est. 2Y upside i
AI powered Lab Operation Management SaaS Platform
Rank
#2106
Sector
Lab Operations Management, AI, IoT
Est. Liquidity
~5Y
Data Quality
Data: MediumiLabService presents a moderate upside opportunity for a job seeker.
Last updated: March 10, 2026
iLabService successfully expands its global footprint, particularly in the Asia-Pacific region, leveraging its 80+ patents and AIoT platform to capture significant market share from traditional lab software and automation providers. With a customer base exceeding 7,700 laboratories, the company achieves strong revenue growth, reaching a valuation of $240M, a 4x multiple of its current assumed valuation.
The company continues to grow steadily, solidifying its position in the intelligent lab operations market. It maintains its competitive edge through ongoing product development and strategic partnerships, leading to an acquisition or IPO at a valuation of $105M, a 1.75x multiple of its current assumed valuation.
Established incumbents like Thermo Fisher Scientific or Agilent Technologies accelerate their AIoT integration, intensifying competition and commoditizing parts of iLabService's offering. Slower-than-expected market adoption or execution challenges lead to a down round or unfavorable exit, reducing the company's valuation to $15M, significantly impacting common stock value due to liquidation preferences.
Preference Stack Risk
highInvestors hold $15.6M in liquidation preferences, representing 26% of the assumed $60M current valuation.
Dilution Risk
highAs a Series A company, iLabService will likely require multiple additional funding rounds, leading to further dilution for existing equity holders.
Secondary Liquidity
noneThere is currently no active secondary market or tender offer for iLabService's shares.
Questions to Ask at the Interview
Strategic questions based on iLabService's data — designed to show you've done your homework.
- 1
“Given the strong patent portfolio and the stated 'medium' incumbent threat, how does iLabService plan to proactively defend its market position against potential future AIoT integrations by large players like Thermo Fisher Scientific and Agilent Technologies?”
- 2
“With a customer base exceeding 7,700 laboratories and a focus on global expansion, particularly in the Asia-Pacific region, what are the key metrics the company is tracking to measure the success of its market penetration and customer retention strategies?”
- 3
“Considering the recent $15M funding round and the company's Series A stage, what is the anticipated timeline for future funding rounds or a liquidity event, and how does the company plan to manage potential dilution for employees holding equity?”
Community
Valuation Sentiment
Our model estimates -58% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.